Moraes Camila de, Oliveira Camila Andrea de, Amaral Maria Esméria Corezola do, Landini Gabriela Arcurio, Catisti Rosana
Programa de Pós-Graduação de Ciências Biomédicas, Centro Universitário Hermínio Ometto, Uniararas, Araras, SP, Brazil.
Arch Endocrinol Metab. 2017 Jan-Feb;61(1):45-53. doi: 10.1590/2359-3997000000186. Epub 2016 Aug 25.
Complexes like conjugated linoleic acid (CLA) reduce the percentage of body fat by increasing energy expenditure, fat oxidation, or both. The aim of this study was to verify if CLA is able to mimic caloric restriction (CR), and determine the effects of CLA on liver metabolic profile of young adult male Wistar rats.
We divided 36 animals into the following groups: 1) Control; 2) CLA (1% of daily food intake, 21 days, orogastric intubation); 3) Restr (fed 60% of the diet offered to controls); and 4) CLA Restr. Liver tissues were processed for biochemical and molecular or mitochondrial isolation (differential centrifugation) and blood samples were collected for biochemical analyses.
Treatment of the animals for 21 days with 1% CLA alone or combined with CR increased liver weight and respiration rates of liver mitochondria suggesting significant mitochondrial uncoupling. We observed a decrease in adipose tissue leading to insulin resistance, hyperinsulinemia, and hepatic steatosis due to increased liver cholesterol and triacylglycerol levels, but no significant effects on body mass. The expression of hepatic cellular connexins (43 and 26) was significantly higher in the CLA group compared with the Control or Restr groups.
CLA does not seem to be a safe compound to induce mass loss because it upregulates the mRNA expression of connexins and induces hepatic mitochondrial changes and lipids disorders.
共轭亚油酸(CLA)等复合物可通过增加能量消耗、脂肪氧化或两者兼而有之来降低体脂百分比。本研究的目的是验证CLA是否能够模拟热量限制(CR),并确定CLA对年轻成年雄性Wistar大鼠肝脏代谢谱的影响。
我们将36只动物分为以下几组:1)对照组;2)CLA组(每日食物摄入量的1%,持续21天,经口胃插管);3)限制饮食组(喂食量为对照组的60%);4)CLA限制饮食组。对肝脏组织进行生化、分子或线粒体分离(差速离心)处理,并采集血样进行生化分析。
单独用1%CLA或与CR联合处理动物21天,可增加肝脏重量和肝脏线粒体呼吸速率,提示线粒体存在明显解偶联。我们观察到脂肪组织减少,导致胰岛素抵抗、高胰岛素血症和肝脂肪变性,原因是肝脏胆固醇和三酰甘油水平升高,但对体重无显著影响。与对照组或限制饮食组相比,CLA组肝脏细胞连接蛋白(43和26)的表达显著更高。
CLA似乎不是一种安全的诱导体重减轻的化合物,因为它上调连接蛋白的mRNA表达,并诱导肝脏线粒体变化和脂质紊乱。